Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.36 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12758224 | 1.00 | ALDH1A1 (0.40) | ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1 | |
| SCHEMBL9345095 | 0.90 | ALDH1A1 (0.40) | ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1 | |
| SCHEMBL9345103 | 0.90 | ALDH1A1 (0.40) | ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1 | |
| SCHEMBL12310446 | 0.90 | ALDH1A1 (0.40) | ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1 | |
| SCHEMBL801342 | 0.85 | ALDH1A1 (0.41) | ALDH1A1KMT2ASMN1; SMN2RAB9AL3MBTL1 | |
| SCHEMBL22453309 | 0.85 | ALDH1A1 (0.43) | ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1 | |
| SCHEMBL4547548 | 0.84 | ALDH1A1 (0.45) | ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1 | |
| SCHEMBL14456207 | 0.84 | ALDH1A1 (0.45) | ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1 | |
| SCHEMBL13609924 | 0.84 | ALDH1A1 (0.45) | ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1 | |
| SCHEMBL13879916 | 0.82 | POLB (0.38) | ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190285773-A1 | LENS FOR SPECTACLES, SPECTACLES, PROTECTIVE SHEET, AND DISPLAY | FUJIFILM CORPORATION (JP) | 2019-09-19 | — | — | US | disclosed |
| US-8829192-B2 | Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives | BASF SE (DE) | 2014-09-09 | — | — | US | disclosed |
| US-20090264657-A1 | Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives | CIBA CORPORATION | 2009-10-22 | — | — | US | disclosed |
| US-20080076940-A1 | PROCESS FOR PRODUCING S-AMINOPENTADIENOATE COMPOUND | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264657-A1 | Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives | ERCC5, XRCC6, XRCC5 | ALDH1A1 597/4885KMT2A 2802/4885SMN1; SMN2 1422/4885 |
| US-20080076940-A1 | PROCESS FOR PRODUCING S-AMINOPENTADIENOATE COMPOUND | AASDHPPT, ADH1A, SSR4 | ALDH1A1 422/4885KMT2A 3013/4885SMN1; SMN2 3669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.